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ABSTRACT  
Magnesium alloys are amidst the most innovative materials for biomedical applications, as they show a set 
of unique properties, namely appropriate mechanical properties and biodegradability, when compared to 
other alloys. Although these properties make them suitable for medical implants, the main challenge is the 
uncontrolled corrosion. Mg degradation is fast, inhomogeneous, localized and often accompanied by 
hydrogen formation which can lead to complications in vivo. Here, we propose the development of a 
functional coating, containing natural-based capsules for the controlled release of biocompatible corrosion 
inhibitors and well known pharmaceutical agents. Empty and loaded capsules toxicity tests were performed 
as a first step for materials selection. Subsequently, they were incorporated into polyetherimide (PEI) 
coatings and tested using electrochemical impedance spectroscopy (EIS) under aggressive conditions.  
The obtained results showed a successful synthesis of natural-based microcapsules, constituting a fast, 
simple and environmentally friendly method. Additionally, the high cell proliferation observed in the 
presence of the aforementioned materials demonstrates their low toxicity. Preliminary results carried out 
with capsule-modified coatings show that the incorporation of Ca2+-loaded gelatin capsules in PEI coatings 
leads to barrier and active corrosion protection properties improvement and that anti-inflammatory agent 
ibuprofen may have a role in active corrosion protection as well. 
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1   INTRODUCTION  
Metals have been playing an essential role in several biomedical devices, being more suitable for load 
bearing applications than ceramic or polymeric materials [1-3]. However, the possible release of toxic 
products through corrosion processes, can lead to complications that may ultimately require the removal of 
the implant [4]. An adequate solution for this problem is the use of biodegradable implants but, their 
insufficient mechanical properties for bone implant application and non-suitable degradation rates [1, 5] are 
a disadvantage. Magnesium alloys seem to combine the best features of both ceramic and polymeric 
materials, with their light-weight, low density and mechanical properties, along with biocompatibility and in 
vivo importance, due to Mg2+ fundamental role in several metabolic processes, making them more suitable 
for medical implants. Nevertheless, Mg alloys are prone to uncontrolled corrosion which hinders their 
application due to H2 evolution and pH increase [6]. Therefore, the use of Mg alloys requires a control over 
its degradation rate in order to allow the body to gradually deal with products resulting from corrosion [2]. 
Protective coatings have been used in different applications in corrosion engineering. Often, corrosion 
inhibitors can be added to the coating matrix to impart active protection, but leaching of inhibitors and 
negative reaction between the coating matrix and these species are potential limitations. This problem has 
been tackled by the encapsulation of inhibitors in inert capsules before their introduction into coating 
formulations [8]. Although successful in different areas such as aeronautical industry, this strategy has never 
been truly implemented in the control of degradation processes of biomaterials by corrosion, with only a few 
reports of synthetic polymers [5, 9] used as biodegradable coatings for Mg-based alloys being available. The 
main innovation of this work is the attempt to control the rate of degradation by corrosion of Mg-based 
implants by controlled release of corrosion inhibiting species and other relevant molecules (for control of 
infectious responses) from bioabsorbable polymer coatings loaded with functional capsules. 
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2   MATERIALS  
Calcium nitrate tetrahydrate (99%), ibuprofen sodium salt (>=98%), coumarin (99%), gelatin from bovine 
skin (gel strength 225 bloom type B), D-glucose (ACS reagent), sodium chloride (ACS reagent) and N-N’-
dimethylacetamide (99%) were purchased from Sigma-Aldrich and used without further purification. 
Polyetherimide ULTEM 1000®  was purchased from General Electric and AZ31 from Magnesium Elektron 
(Manchester, UK). 
2.1  Synthesis  of  gelatin  capsules  
Gelatin capsules were produced by a thermal gelation method using a published procedure [10] with minor 
modifications. Briefly, 0.4 g of D-glucose were added to 20 mL of a 20% w/v aqueous gelatin solution 
preheated in a water bath at ~50 ºC and added dropwise to 200 mL of sunflower oil containing 1% v/v of 
Span® 85, while stirring at 80 ºC, for 10 min. Afterwards, the w/o emulsion was moved into an iced water 
bath and stirring was continued until ~15 ºC were reached. Then, 150 mL of acetone were added to promote 
dehydration and flocculation of the microspheres. After 10 min of stirring, the microspheres were filtered 
through a sintered glass filter and washed with 250 mL of acetone to remove any traces of oil. The spheres 
were then dried under vacuum to remove the remaining acetone. Glucose crosslinked gelatin microspheres 
were prepared in deionized water (empty) and in Ca2+, Ibuprofen and Coumarin aqueous solutions. 
2.2  Capsule  characterization  
Small samples of the synthesized gelatin capsules were placed on double sided carbon tape and sputtered 
with Au/Pd for 3 min. Particle morphology was characterized by scanning electron microscopy (SEM) 
(Hitachi S-4100 system with electron beam energy of 25 keV). Image J software (freeware) was used to 
analyze the obtained data. FTIR analyses of empty and loaded gelatin capsules were carried out on a Bruker 
Tensor 27 Spectrometer coupled with an ATR device, 128 scans and 4 cm-1 resolution, in the range from 
4000-400 cm-1.  
2.3  Toxicity  assessment  
Cytotoxicity testing of coating components was performed in a L929 mouse connective tissue cell line 
according to ISO 10993-5:2009. The materials tested included corrosion inhibitors (calcium nitrate 
tetrahydrate), D-glucose crosslinked gelatin capsules either empty or loaded with Ca2+. The test items were 
freshly prepared in FBS-free cell culture medium (MEM supplemented with 2 mM L-glutamine, 100 
units/mL of penicillin and 100 µg/mL of streptomycin). The cells were exposed to the test items for 24 h and 
cytotoxicity evaluated using two well-established endpoints: LDH release, an indicator of plasma membrane 
integrity and WST-1 reduction, to assess cell proliferation and metabolic activity. 
2.4  Polyetherimide  coatings  
Prior to coating, the metal was pre-treated according to a published procedure [11]. Coated AZ31 Mg alloys 
with 10% PEI in dimethylacetamide were prepared by manual dip coating. Pre-treated substrates were 
immersed in PEI coating formulation for 60 s, removed and left to dry for ~3 min under room conditions 
(temperature, moisture). After this resting period, the substrates were immersed once again in PEI polymer 
solution for 10 s and left to dry overnight [12]. 
2.5  Electrochemical  impedance  studies  
EIS measurements were carried out in a three-electrode cell with a SCE reference electrode, platinum foil 
counter electrode and the coated magnesium alloy sample as the working electrode (exposed area of  
~3.30 cm2). The cell was placed in a Faraday cage to avoid the interference of external electromagnetic 
fields. Measurements were performed using a Gamry FAS2 Femtostat with PCI4 Controller. The selected 
frequency range was from 105 to 10-2 Hz, with a 10 mV of sinusoidal perturbation with 7 points per 
frequency decade. All spectra were recorded at open circuit potential. 
3   RESULTS  
3.1  Synthesis  
Gelatin capsules were successfully produced by a thermal gelation method, as described previously by 
Hiwale et al, through a water in oil emulsion with Span®85 as surfactant and D-glucose as a crosslinking 
agent. Empty and loaded capsules presented gelatins’ characteristic yellowish colour and were obtained as a 
loose powder. 
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3.2  Characterization  
Scanning  Electron  Microscopy  
All capsules present a spherical morphology and heterogenous size distribution. As it is also possible to 
observe, gelatin capsules with anti-inflammatory agents such as ibuprofen have a slightly distorted 
morphology but nevertheless are considered spherical. Gelatin capsules size range from ~9 to 26 µm. 
  
  Figure  1.  (left  to  right)  Empty  gelatin  capsules  crosslinked  with  glucose  (Glu@gel),  calcium-­loaded  
and  ibuprofen  gelatin  capsules  crosslinked  with  glucose  (Ca@gel  and  Ibu@gel,  respectively).  
Fourier  Transformed  Infrared  Spectroscopy  
The process of gelatin crosslinking may occur by one or several reactions (Figure 2). One possible 
mechanism is the reaction of the aldehyde group of the sugar with free amino groups of the gelatin molecule, 
resulting in the formation of an aminoglycoside which, in  turn, can further react with another amine group 
from gelatin leading to a crosslinked structure [13]. 
 
 
Figure  2.  Schematic  representation  of  the  D-­Glucose  mediated  gelatin  crosslinking  reaction  
mechanism  (adapted  from  [8]).  
In all of the FTIR spectra presented (Figure 3), the characteristic absorption peaks of the protein backbone 
(NH and CO stretching) are observed. 
 
 
Figure  3.  ATR  spectra  of  the  synthesized  gelatin  capsules  
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The NH stretching referred to as amide A peak is observed at ∼3300 cm-1 while CO stretching peaks 
referred to as amides I, II and III were found at ∼1650, 1550, and 1240 cm-1, respectively [10, 13]. 
Interestingly, the intensity of the CO stretching peaks was the highest for empty glucose crosslinked 
capsules and a decrease in intensity is observed when encapsulation with different compounds is performed, 
which suggests that functional groups from the active species may compete, at some point, with glucose to 
form bonds with gelatin functional groups. The presence of asymmetric and symmetric CH2str vibrations at 
~2924 and 2853 cm-1, respectively, suggests the presence of glucose crosslinked to the gelatin 
aminoglycoside moieties. The presence of a band at ~1740 cm-1 (identified by the arrow) is assigned to  
C=Ostr (enol form) vibrations and is attributed to D-glucose HC=O moieties (keto-enol tautomerization and 
aminoglycoside formation), which further confirms that crosslinking occurred [14]. 
3.3  Toxicity  Assessment  
LDH and WST-1 reduction assays were performed for the actives species under study (results not shown) as 
well as for empty and calcium-loaded gelatin capsules. The obtained results did not show significant 
differences in LDH release, when compared to the control and no WST-1 decrease, which shows that Ca2+ is 
non/low toxic. In what concerns the anti-inflammatory agents tested, coumarin did not induce toxicity in 
L929 as assessed by both LDH and WST-1 assays. However, ibuprofen sodium increased LDH release and 
decreased WST-1 reduction in a concentration-dependent manner, being this effect more evident for the 
highest concentrations tested (950 and 1900 µM).  
 
Figure  4.  Effect  of  different  concentrations  of  empty  and  Ca2+-­loaded  capsules  on  L929  cell  
viability  as  assessed  by  the  LDH  release  (A)  and  WST-­1  reduction  (B)  assays.  Cells  were  exposed  
to  different  concentrations  (1-­5  mg/mL)  of  the  test  agents  for  24  h.  Results  are  presented  as  mean  
±  SD  of  one  experiment  (n  =  3  replicates  per  group).  
As it can be seen, in Figure 4A, no changes in LDH release are observed for empty gelatin capsules but a 
concentration-dependent increase in WST-1 reduction (Figure 4B) was observed in the gelatin capsules-
exposed cells, which is most likely due to the D-glucose content of the capsules and its consequent 
proliferative effect. The same effect can be observed for the calcium-loaded capsules, confirming the low 
toxicity of the gelatin capsules. 
3.4  EIS  Studies  of  PEI  Coatings  Containing  Capsules  –  Coating  Performance  
The degradation of AZ31 in NaCl without coating (results not shown) can already be seen at early stages 
immersion by the low impedance magnitude values obtained (<0.5 kΩ cm2). One time constant at ~100 Hz is 
observed and attributed to electrochemical processes occurring at the metal interface. When a PEI coating is 
applied, the initial impedance magnitude goes up two orders of magnitude and a second time constant at 
high frequencies is detected (around 105 Hz), associated with the presence of this organic coating layer. 
However, with increase in immersion time, the porous nature of PEI leads to a fast decrease in the coating 
barrier properties. The addition of gelatin microcapsules loaded with different species causes an initial 
decrease in the impedance values across the whole frequency range (due to their hydrophilic nature or some 
sort of barrier weakening that facilitates conducting pathways for ingress of electrolyte). Nevertheless, over 
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time, some systems seem to perform better than the bare PEI coating. Figure 5 depicts the EIS spectra for all 
the systems after 48h of immersion (left) and magnitude of impedance at 0.2 Hz (right).  
Figure  5.  (left)  Bode  plots  of  EIS  (|Z|  (Ohm.cm2)  spectra  and  (right)  impedance  magnitude  values  
at  0.2  Hz  for  all  coatings  systems  studied.    
It is possible to observe that coatings with Ca- and ibuprofen-loaded gelatin microcapsules are the best 
systems. While for Ca-containing gelatin the coating performs better than bare PEI across the whole 
frequency range, the ibuprofen-gelatin microcapsules leads to slightly lower barrier properties, though the 
second time-constant at intermediate frequencies shows higher impedance magnitude. This may be related to 
some sort of active effect of the capsules directly in the corrosion processes ongoing at the interface. 
Visually (photos not shown) the different coating systems show some changes due to immersion and 
corrosion processes. The degradation of the coating layer leads, in some cases, to a detachment of the 
coating from the surface of the substrate. 
4   CONCLUSIONS  
Gelatin capsules were synthesized successfully by a fast, simple and environmentally-friendly approach. 
They were characterized physicochemically and although positive and promising results have been achieved, 
a more effective crosslinking of the gelatin backbone with D-glucose must be investigated, as well as a 
higher encapsulation/immobilization efficiency should be achieved in order to increase the amount of active 
species in the capsules. 
Regarding the toxicity results, the selected species (calcium, ibuprofen and coumarin) as well as the 
respective gelatin capsules can be assumed as low toxic species. The toxicity associated with ibuprofen for 
higher concentrations is somehow expected taking into account its biological role. The dose-effect achieved 
within the final coatings will have to be determined in order to infer on possible toxic effects. 
In what concerns PEI coatings, they were prepared, tested with gelatin microcapsules loaded with different 
species and applied on AZ31 Mg alloys. PEI coatings with Ca2+-loaded gelatin microcapsules showed higher 
impedance magnitude values at both high and low frequencies, when compared to PEI and PEI loaded with 
empty gelatin capsules. Although these are preliminary results it is possible to observe an improvement of 
barrier and active corrosion protection properties, respectively. Additionally, ibuprofen seems to play some 
role in terms of active corrosion protection as well, which is a promising double-feature for the ibuprofen 
gelatin capsules since they might act both as anti-inflammatory agents and corrosion inhibiting species for 
the underlying metallic substrate. 
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